Neuropathy Risk Breast Cancer Interventions

active
URL
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.418
Version
20161223
PublisherOncology Nursing Society StewardDate2016-12-23T01:00:03-05:00Description

ONS measure set

Purpose

(Clinical Focus: This set of values contain treatments of breast cancer that have a side effect of Neuropathy.),(Data Element Scope: Data element would map to the QDM Medication category.),(Inclusion Criteria: Breast cancer treatments that have a side effect of Neuropathy.),(Exclusion Criteria: Treatments not used for breast cancer that have a side effect of Neuropathy..)

Expansion
<<>>>
CodeDisplaySystem
61864009http://snomed.info/sct
84847000http://snomed.info/sct
105863000http://snomed.info/sct
409199002http://snomed.info/sct
418965003http://snomed.info/sct
309311http://www.nlm.nih.gov/research/umls/rxnorm
245839http://www.nlm.nih.gov/research/umls/rxnorm
1093280http://www.nlm.nih.gov/research/umls/rxnorm
346209http://www.nlm.nih.gov/research/umls/rxnorm
313949http://www.nlm.nih.gov/research/umls/rxnorm
239178http://www.nlm.nih.gov/research/umls/rxnorm
376433http://www.nlm.nih.gov/research/umls/rxnorm
1663181http://www.nlm.nih.gov/research/umls/rxnorm
377037http://www.nlm.nih.gov/research/umls/rxnorm
376888http://www.nlm.nih.gov/research/umls/rxnorm
894899http://www.nlm.nih.gov/research/umls/rxnorm
1376083http://www.nlm.nih.gov/research/umls/rxnorm
894900http://www.nlm.nih.gov/research/umls/rxnorm
1304995http://www.nlm.nih.gov/research/umls/rxnorm
894892http://www.nlm.nih.gov/research/umls/rxnorm